Bioinformatic analysis and experimental verification reveal expansion of monocyte subsets with an interferon signature in systemic lupus erythematosus patients
Jimin Zhang,
No information about this author
Wuwei Zhuang,
No information about this author
Li Y
No information about this author
et al.
Arthritis Research & Therapy,
Journal Year:
2025,
Volume and Issue:
27(1)
Published: April 25, 2025
Systemic
lupus
erythematosus
(SLE)
is
a
complex
autoimmune
disorder
characterized
by
chronic
inflammation
and
multi-organ
damage.
A
central
factor
in
SLE
pathogenesis
the
excessive
production
of
type
I
interferon
(IFN-I),
which
drives
immune
dysregulation.
Monocytes,
key
components
system,
significantly
contribute
to
IFN-I
production.
However,
their
specific
roles
remain
incompletely
understood.
This
study
utilized
bioinformatics
statistical
analyses,
including
robust
rank
aggregation
(RRA),
DESeq2,
limma,
analyze
transcriptome
data
from
peripheral
blood
mononuclear
cells
(PBMCs)
monocytes
patients
healthy
controls.
Single-cell
RNA
sequencing
(scRNA-seq)
were
processed
using
Seurat
R
package
identify
characterize
monocyte
subsets
with
strong
IFN-driven
gene
signature.
Flow
cytometry
was
employed
validate
findings,
markers
such
as
CD14,
SIGLEC1,
IRF7
confirm
subset
composition.
Our
research
has
found
that
undergo
transcriptional
reprogramming,
upregulation
signature
genes
(ISGs),
forming
SLE-Related
Monocyte
Signature
(SLERRAsignature).
Moreover,
composition
phagocyte
changes,
an
increase
trend
proportion
CD14Mono8
flare
group.
The
differentially
expressed
(DEGs)
13
are
mainly
ISGs,
expression
ISGs
higher
severe
patients.
We
identified
SIGLEC1+IRF7+
among
these
for
first
time
discovered
this
group
individuals.
In
SLE,
enrichment
score
set
representing
positively
correlated
severity
SLE.
Finally,
flow
confirmed
frequency
CD14+SIGLEC1+IRF7+
PBMCs
compared
expansion
IFN-I-producing
subsets,
particularly
subset,
plays
crucial
role
pathogenesis.
may
serve
potential
biomarker
therapeutic
target
managing
Language: Английский
Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 63 - 63
Published: Dec. 25, 2024
Mitochondrial
dysfunction
and
macrophage
dysregulation
are
well
recognized
as
significant
contributors
to
the
pathogenesis
of
autoimmune
diseases.
However,
detailed
mechanisms
connecting
these
two
factors
remain
poorly
understood.
This
study
hypothesizes
that
low
but
chronic
interferon-gamma
(IFN-γ)
plays
a
critical
role
in
processes.
To
explore
this,
we
utilized
ARE-Del
mice,
model
characterized
by
sustained
low-level
IFN-γ
expression
lupus
nephritis
(LN)-like
symptoms.
Age-
tissue-dependent
gene
analyses
mice
revealed
suppression
mitochondrial
complex
I
components
activities,
particularly
kidneys.
The
genotype-dependent
indicates
early
disruption,
which
leads
dysfunction.
Notably,
remission
restored
isolated
renal
macrophages
from
NZB/W
lupus-prone
mice.
These
findings
suggest
disrupts
activity
macrophages,
highlighting
its
diseases
like
nephritis.
provides
new
insights
into
molecular
interactions
underlying
suggests
potential
targets
for
therapeutic
intervention.
Language: Английский